Rep. A. Drew Ferguson IV

Maddy summaryThe FOCA Act of 2023 requires federal agencies to stop mandating or banning contractor agreements with labor organizations (like union contracts) in construction project bids and contracts. It directly affects federal contractors, subcontractors, and agencies managing construction projects funded by the government. The bill prohibits favoring or penalizing contractors based on their labor affiliation status, aiming to promote fair competition and reduce costs. It also mandates updates to federal contracting rules within 60 days of enactment to implement these changes.

Maddy summaryThis bill amends Medicare payment rules to provide additional funding to hospitals in low-wage areas. It directly affects hospitals with Medicare payment rates based on local wages that fall below the 25th percentile nationally. The key provision increases these hospitals' Medicare payment rates by half the difference between their current rate and the 25th percentile rate, applied in a budget-neutral way. This adjustment applies to patient discharges on or after October 1, 2019, and aims to support financially struggling hospitals in low-wage regions.

Maddy summaryThe ANTE Act gives the U.S. International Trade Commission (USITC) new authority to investigate whether companies owned by non-market economy countries (like China or Russia, as defined by U.S. trade agencies) are using third countries (e.g., Vietnam or Mexico) to avoid U.S. tariffs on their goods. If the USITC finds evidence of tariff evasion - such as production in a third country to bypass tariffs on goods from a non-market economy - it can recommend trade remedies to the President or Congress. These remedies could include targeted tariffs on the third-country investment or broader import restrictions, requiring Congress to act within 60 days via a joint resolution. The policy would last 3-8 years, with automatic review before expiration to assess if the evasion threat persists. This directly affects companies in non-market economies seeking to circumvent U.S. trade penalties through third-country operations.

Maddy summaryHR 9272, the Catastrophic Specialty Hospital Act of 2024, creates a new Medicare payment designation for specialized long-term care hospitals treating spinal cord injuries and acquired brain injuries. To qualify, hospitals must meet strict criteria over a 3-year period, including having at least 80% of discharges related to these conditions, offering comprehensive inpatient and outpatient care, meeting minimum discharge thresholds (175+ for each injury type), having 30% out-of-state patients, and demonstrating research or accreditation in neurorehabilitation. Qualified hospitals would receive Medicare payments under a separate system, exempt from standard long-term care hospital payment rules. This bill directly affects specialized rehabilitation hospitals meeting these criteria, not general Medicare beneficiaries.

Maddy summaryThe University Accountability Act imposes penalties on tax-exempt universities found in federal court to have violated Title VI of the Civil Rights Act of 1964, requiring them to pay $100,000 or 5% of their administrative compensation per violation. It mandates the IRS to review the tax-exempt status of institutions with more than two such violations and requires these institutions to report civil rights violations on their tax returns. If a violation determination is overturned, the penalty must be refunded. The bill applies to most public and private universities that are tax-exempt under federal law, directly affecting their financial obligations and reporting requirements.

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2027 and publish detailed data on their approval and denial rates for medical services by 2026. It directly affects Medicare Advantage plans (private insurers offering Medicare coverage) and their enrollees (seniors 65+), mandating transparency about prior authorization decisions, processing times, and appeal outcomes. Key provisions include requiring plans to report annual statistics on request approvals/denials, average processing times, and use of technology, with this data published publicly by the Centers for Medicare & Medicaid Services. The bill also sets timelines for plan responses to prior authorization requests and mandates reports to Congress on implementation and impacts.

Maddy summary# Summary of Tariff Suspensions and Reductions Document This document is a section of U.S. tariff legislation that adds new duty suspensions and reductions to the Harmonized Tariff Schedule of the United States. It contains 120 new tariff items (numbered 9902.19.01 through 9902.20.24) that provide temporary duty-free or reduced-duty status for various goods. Key features of the document: 1. **Content**: The list includes chemical compounds, food ingredients, and specialty materials (such as shelled pine nuts, licorice extract, refined carrageenan, various chemicals like neodymium metal, tungsten concentrate, and numerous organic compounds). 2. **Tariff Treatment**: Most entries are listed as "Free" (meaning duty-free), with a few having small duty rates (e.g., 0.7%, 1.8%, 2.3%, 2.9%, 4.3%). 3. **Effective Period**: All listed suspensions and reductions are effective "On or before 12/31/2025." 4. **Purpose**: These tariff suspensions are intended to support specific industries, reduce costs for manufacturers, or provide temporary relief for certain imported goods. 5. **Technical Details**: Each entry includes the chemical name, CAS number, Harmonized Tariff Schedule code, duty rate, and a brief description of the product. This document represents a legislative amendment to the Harmonized Tariff Schedule, specifically adding new subchapter II of chapter 99 to provide temporary duty relief for these specific items.

Maddy summaryHR 7142 (Alternatives to PAIN Act) requires Medicare Part D plans to cover non-opioid pain management drugs with no deductible and at the lowest copay level starting in 2025. It defines "qualifying non-opioid drugs" as FDA-approved medications that don’t act on opioid receptors (like certain NSAIDs or nerve pain treatments), excluding opioids and schedule I-III drugs. The bill prohibits Medicare plans from forcing patients to try opioids first (step therapy) or requiring prior approval for these non-opioid options. It directly affects Medicare beneficiaries needing pain management, especially those seeking alternatives to opioids for post-surgical or acute pain. The policy change aims to improve access to non-addictive pain treatments while preserving doctors' authority to prescribe medically appropriate care.

Maddy summaryThis bill, HR 6860, protects patients with end-stage kidney disease (ESRD) who require dialysis by preventing health insurance plans from discriminating against them. It amends Medicare rules to prohibit plans from treating dialysis coverage differently than other medical services based on a patient’s ESRD diagnosis, need for dialysis, or any other factor. The bill clarifies that plans can still choose which dialysis providers to include in their networks but cannot deny or limit coverage for dialysis services solely because of the patient’s condition. It ensures Medicare remains the secondary payer for these services as intended, without forcing plans to cover specific providers.

Maddy summaryThe Preserving Seniors’ Access to Physicians Act of 2023 increases the Medicare payment adjustment rate for physicians from 1.25% to 4.62%, directly affecting doctors who treat Medicare patients (primarily seniors). It also reduces the funding for the Medicaid improvement fund from $5,796,117,810 to $3,973,117,810. These changes impact Medicare providers and Medicaid programs, with the Medicare adjustment aimed at supporting physicians adjusting to payment changes. The bill does not specify how the Medicaid funding reduction relates to its stated goal of preserving seniors' access to physicians.